Prifetrastat clinical trials
Also written PF-07248144.
How each study uses prifetrastat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the prifetrastat studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
9 studies that test it; most in 2025 (5)
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2025 | 5 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 8 · Other 1
Often tested with
Tested in the same studies.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1, 1 in phase 3
Studies that test prifetrastat, phase 3 first.
Studies
Open first, then newest update. How each study uses prifetrastat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 9
- Study of PF-07248144 in Advanced or Metastatic Solid TumorsRecruitingPhase 2PfizerNCT04606446Written as PF-07248144
- A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.RecruitingPhase 3PfizerNCT07062965Written as PF-07248144
- Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) and HER2 Negative (HER2-) Breast Cancer Extended to Other Organs.Not yet recruitingPhase 2UNICANCERNCT07340619Written as prifetrastat in combination with fulvestrant
- A Study to Learn About How Food Affects the Uptake of Study Medicine Prifetrastat Into the Blood in Healthy AdultsNot yet recruitingPhase 1PfizerNCT07731100Written as Prifetrastat
- A Study to Learn if Itraconazole Changes How the Body Processes PF-07248144 (Study Medicine)CompletedPhase 1PfizerNCT07335419Written as PF-07248144
- A Study to Learn if the Study Medicine Called Fluconazole Changes How the Other Body Processes the Study Medicine PF-07248144CompletedPhase 1PfizerNCT07636018Written as PF-07248144
- A Study to Learn if Multiple Doses of the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine PF-07248144CompletedPhase 1PfizerNCT07198035Written as PF-07248144
- A Study to Understand What the Body Does to the Study Medicine Called PF-07248144 When Taken by Healthy AdultsCompletedPhase 1PfizerNCT07423286Written as Oral [14C] PF-07248144
- A Study to Learn About How Different Forms of Study Medicine PF-07248144 Are Taken Up Into the Blood in Healthy AdultsCompletedPhase 1PfizerNCT07117799Written as PF-07248144
Codes
What other systems call prifetrastat · ClinicalTrials.gg INT016685
- UNII (FDA) GN6DU4ZE30PRIFETRASTATConfirmed FDA, Wikidata
- Wikidata Q137035408prifetrastatConfirmed FDA, Wikidata
- NCI Thesaurus C178474PrifetrastatOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | GN6DU4ZE30 | PRIFETRASTAT | Confirmed FDA, Wikidata |
| Wikidata | Q137035408 | prifetrastat | Confirmed FDA, Wikidata |
| NCI Thesaurus | C178474 | Prifetrastat | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.